Richard Demasi, MD
Vascular Surgery · Virginia Beach, VANPI 1619948072
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 68.1% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $24,352 and has fallen 97.9% since, to $523 in 2025. Among vascular surgery clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 295 payments — averaging $189.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$38K
- Medtronic$5K
- Inari Medical, Inc.$2K
- Silk Road Medical, Inc.$2K
- W. L. Gore & Associates, Inc.$2K
- Cardiovascular Systems Inc.$1K
- plus $6K from 20 others
What the payments were for
- Consulting fees$20,07536%
- Speaking & faculty fees$16,00029%
- Travel & lodging$1,1512%
- Food & beverage$18,66233%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 50 | $38,099 |
| Medtronic(2 entities) | 57 | $5,222 |
| Inari Medical, Inc. | 57 | $2,340 |
| Silk Road Medical, Inc. | 21 | $1,673 |
| W. L. Gore & Associates, Inc. | 17 | $1,614 |
| Cardiovascular Systems Inc. | 17 | $1,261 |
| Endologix LLC | 9 | $971 |
| Cook Medical LLC | 13 | $827 |
| Bolton Medical Inc | 7 | $782 |
| Abbott | 7 | $586 |
| Penumbra, Inc. | 7 | $534 |
| Philips North America LLC | 6 | $501 |
| KCI USA, Inc. | 3 | $217 |
| Boston Scientific | 2 | $207 |
| Smith+Nephew | 5 | $195 |
| Shockwave Medical, Inc | 1 | $176 |
| Baxter Healthcare | 4 | $166 |
| Surmodics, Inc. | 1 | $119 |
| Cardinal Health 200 LLC | 2 | $108 |
| Johnson & Johnson | 1 | $97 |
| Cordis US CORP. | 3 | $91 |
| GE HealthCare | 1 | $80 |
| Getinge USA Sales, LLC | 1 | $30 |
| Tactile Systems Technology Inc | 1 | $25 |
| Misonix Inc | 1 | $17 |
| Lemaitre Vascular, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLUENCY$21,000
- ENDURANT IIS$2,811
- FLOWTRIEVER CATHETER, S$2,208
- ENROUTE Transcarotid Neuroprotection System$1,282
- Endurant$818
- ENROUTE Transcarotid Stent$801
- CT THROMBECTOMY SYSTEM KIT$685
- Diamondback Peripheral$608
- GORE EXCLUDER AAA Endoprosthesis$526
- C3 Delivery System$514
- ENHANCE Transcarotid Peripheral Access Kit$392
- Grafts$338
- ENROUTE Transcarotid Stent System$237
- ENROUTE 0.014 Guidewire$237
- Peripheral Orbital Atherectomy System$224
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$176
- TREO ABDOMINAL STENT-GRAFT SYSTEM$170
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$170
- ENROUTE .014 Guidewire$155
- OMNILINK ELITE$154
How this compares
$55,953 in reported general payments places this provider in the 90th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 11 | $13,663 |
| ClopidogrelClopidogrel Bisulfate | 33 | $251 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $106 |
| Gabapentin | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $97 | $13,66311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 143 vascular surgery providers in Virginia.
Other vascular surgery in Virginia Beach
- Jean PannetonVirginia Beach$1.3M
- Samuel SteermanVirginia Beach$252K
- Hosam El SayedVirginia Beach$60K
- Siddharth BhendeVirginia Beach$56K
- Christopher MurterVirginia Beach$28K
- Priyam VyasVirginia Beach$15K
- Sadaf AhanchiVirginia Beach$12K
- John DeitrickRichmond$684K
- Rasesh ShahChesapeake$465K
- David DexterNorfolk$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.